Gackler A.; Schonermarck U.; Dobronravov V.; La Manna G.; Denker A.; Liu P.; Vinogradova M.; Yoon S.-S.; Praga M., Correction to: Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis (BMC Nephrology, (2021), 22, 1, (5), 10.1186/s12882-020-02190-0), «BMC NEPHROLOGY», 2021, 22, pp. 1 - 1 [Comment or similar]Open Access
Rondeau E.; Scully M.; Ariceta G.; Barbour T.; Cataland S.; Heyne N.; Miyakawa Y.; Ortiz S.; Swenson E.; Vallee M.; Yoon S.-S.; Kavanagh D.; Haller H.; Babu S.; Broeders N.; Lietar N.; Brown F.; Campbell P.; Campistol J.M.; Blasco M.; Chowdhury P.; Kasimatis T.; Cirami L.; Caroti L.; Antognoli G.; Delmas Y.; Dobronravov V.; Gaeckler A.; Garrouste C.; Greenwood G.; Griffin S.; Huang C.-C.; Chen I.-R.; Huang S.; Kim J.S.; La Manna G.; Comai G.; Cappuccilli M.; Le Quintrec M.; Jeantet G.; Fumie I.; Luque Y.; Menne J.; Morelle J.; Goffin E.; Muhlfeld A.; Nagaraj S.; Arepally G.; Oh D.; Okumi M.; Terente M.P.; Gutierrez E.; Rodriguez P.; Provot F.; Schonermarck U.; Fischereder M.; Terrada N.R.; Seitz-Polski B.; Favre G.; Boyer-Suavet S.; Vinogradova M.; Kirsanova T.; Wong E.K.S., Corrigendum to “Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D and Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.” Kidney Int. 2020;97:1287–1296 (Kidney International (2020) 97(6) (1287–1296), (S0085253820301526), (10.1016/j.kint.2020.01.035)), «KIDNEY INTERNATIONAL», 2021, 99, pp. 1244 - 1244 [Comment or similar]
Bruno, P. F.; Cappuccilli, M.; Spazzoli, A.; De Liberali, M.; Sejdiu, B.; Napoli, M.; Minerva, V.; Semprini, S.; Dirani, G.; Sambri, V.; Buscaroli, A.; Rigotti, A.; Mancini, E.; Masperi, P.; La Manna, G.; Mosconi, G., COVID-19 Infection: Viral Clearance and Antibody Response in Dialysis Patients and Renal Transplant Recipients, «NEPHRON JOURNALS», 2021, 145, pp. 363 - 370 [Scientific article]
Cozzolino M.; Conte F.; Zappulo F.; Ciceri P.; Galassi A.; Capelli I.; Magnoni G.; La Manna G., COVID-19 pandemic era: is it time to promote home dialysis and peritoneal dialysis?, «CLINICAL KIDNEY JOURNAL», 2021, 14, pp. I6 - I13 [Scientific article]
Cianciolo G.; Tondolo F.; Barbuto S.; Iacovella F.; Zavatta G.; Altieri P.; Grandinetti V.; Comai G.; Cozzolino M.; La Manna G., Denosumab-Induced Hypocalcemia and Hyperparathyroidism in de novo Kidney Transplant Recipients, «AMERICAN JOURNAL OF NEPHROLOGY», 2021, 52, pp. 611 - 619 [Scientific article]
Donati, Gabriele; Angeletti, Andrea; Gasperoni, Lorenzo; Piscaglia, Fabio; Croci Chiocchini, Anna Laura; Scrivo, Anna; Natali, Teresa; Ullo, Ines; Guglielmo, Chiara; Simoni, Patrizia; Mancini, Rita; Bolondi, Luigi; La Manna, Gaetano, Detoxification of bilirubin and bile acids with intermittent coupled plasmafiltration and adsorption in liver failure (HERCOLE study), «JN. JOURNAL OF NEPHROLOGY», 2021, 34, pp. 77 - 88 [Scientific article]Open Access
Porcelli B.; Guarnieri A.; Ferretti F.; Garosi G.; Terzuoli L.; Cinci F.; Tabucchi A.; Tampoia M.; Abbracciavento L.; Villani C.; Deleonardi G.; Grondona A.G.; Mazzolini M.; La Manna G.; Santostefano M.; Infantino M.; Manfredi M.; Spatoliatore G.; Rosati A.; Somma C.; Bizzaro N., Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience, «JN. JOURNAL OF NEPHROLOGY», 2021, 34, pp. 573 - 579 [Scientific article]Open Access
Gackler A.; Schonermarck U.; Dobronravov V.; La Manna G.; Denker A.; Liu P.; Vinogradova M.; Yoon S.-S.; Praga M., Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis, «BMC NEPHROLOGY», 2021, 22, Article number: 5 , pp. 1 - 9 [Scientific article]Open Access
Guglielmo, C.; Bin, S.; Cantarelli, C.; Hartzell, S.; Angeletti, A.; Donadei, C.; Cumpelik, A.; Anderson, L.; Cody, E.; Sage, P. T.; la Manna, G.; Fiaccadori, E.; Heeger, P. S.; Cravedi, P., Erythropoietin reduces auto- And alloantibodies by inhibiting T follicular helper cell differentiation, «JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY», 2021, 32, pp. 2542 - 2560 [Scientific article]
La Manna G., Flying at high altitude, «GIORNALE ITALIANO DI NEFROLOGIA», 2021, 38, pp. 1 - 7 [Scientific article]
M. Busutti, V. Cuna, F. Tondolo, V. Bertuzzo, G. Frascaroli, M. Righini, M. Ravaioli, G. Comai, G. La Manna, IL RUOLO DELLA BIOPSIA RENALE NEL DONATORE DI RENE, in: IL RUOLO DELLA BIOPSIA RENALE NEL DONATORE DI RENE, 2021, pp. 1 - 137 (atti di: 44° Congresso NAZIONALE S.I.T.O. 2021, NAPOLI, 3-5 OTTOBRE) [Abstract]
Antonella Troiano, Valeria Corradetti, Giorgia Comai, Claudia Bini,
Federica Maritati, Francesca Ferrara, Matteo Ravaioli, Massimo Del
Gaudio, Gaetano La Manna, ILOPROST INFUSION ACCELERATES THE RECOVER OF RENAL FUNCTION IN PATIENTS EXPERIENCING IRIRELATED DELAYED GRAFT FUNCTION AFTER KIDNEY
TRANSPLANT, in: OP208, 2021, pp. 5 - 404 (atti di: European Society for Organ Transplantation, MILANO, 29 AGOSTO-1 SETTEMBRE) [Contribution to conference proceedings]
Righini, M.; Dalmastri, V.; Capelli, I.; Orsi, C.; Donati, G.; Pallotti, M. G.; Pedone, C.; Casella, G.; Chieco, P.; LA Manna, G., Intravenous Iron Replacement Therapy Improves Cardiovascular Outcomes in Hemodialysis Patients, «IN VIVO», 2021, 35, pp. 1617 - 1624 [Scientific article]
Barbour T.; Scully M.; Ariceta G.; Cataland S.; Garlo K.; Heyne N.; Luque Y.; Menne J.; Miyakawa Y.; Yoon S.-S.; Kavanagh D.; Babu S.; Broeders N.; Lietar N.; Brown F.; Campbell P.; Campistol J.M.; Chowdhury P.; Kasimatis T.; Cirami L.; Caroti L.; Antognoli G.; Delmas Y.; Dobronravov V.; Gaeckler A.; Garrouste C.; Greenwood G.; Griffin S.; Huang C.-C.; Chen I.-R.; Huang S.; Kim J.S.; La Manna G.; Le Quintrec M.; Jeantet G.; Fumie I.; Rondeau E.; Haller H.; Morelle J.; Goffin E.; Muhlfeld A.; Nagaraj S.; Arepally G.; Oh D.; Okumi M.; Terente M.P.; Provot F.; Schonermarck U.; Fischereder M.; Terrada N.R.; Seitz-Polski B.; Favre G.; Boyer-Suavet S.; Vinogradova M.; Kirsanova T.; Wong E.K.S., Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults, «KIDNEY INTERNATIONAL REPORTS», 2021, 6, pp. 1603 - 1613 [Scientific article]Open Access
I. Capelli, M. Zoli, M. Righini, L. Faccioli, V. Aiello, L. Spinardi, D. Gori, F. Friso, A. Rustici, C. Bortolotti, C. Graziano, V. Mantovani, N. Sciascia, D. Mazzatenta, M. Seri, M. Pastore Trossello & G. La Manna, MR Brain Screening in ADPKD Patients, «CLINICAL NEURORADIOLOGY», 2021, 1, pp. 1 - 10 [Scientific article]Open Access
